Sativa Wellness - EU courts clear the way for CBD in Europe
RNS Number : 2062G
Sativa Wellness Group Inc.
24 November 2020
 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION (INCLUDING THE UNITED STATES) WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

24 November 2020

Sativa Wellness Group Inc.
("Sativa Wellness" or the "Company")

EU courts clear the way for CBD in Europe

The European Court of Justice ("ECJ") ruling provides that CBD is not classified as a narcotic drug, and that the French ban on hemp derived CBD contradicts European Union ("EU") law. This decision opens the door for high quality, compliant CBD companies to operate in markets across the EU. Sativa Wellness welcomes this news as the Company operates CBD extraction and production facilities and markets, distributes and sells CBD products throughout the UK and the EU.

 

The Group have embraced the industry regulations in the UK and are on track with their extensive product range for the submission deadline in March 2021 of the UK FSA Novel Foods Accreditation which should now be, subject to the process resuming, an easy transition to the European FSA Novel Foods accreditation.

 

Sativa Wellness holds a unique 'seed to consumer' position in the market, offering consistent quality control of the cannabinoid, full traceability of ingredients, manufacturing and testing with the added reassurance to the customer that each batch is QR coded which tracks back to its testing report.

 

From this enviable position the Company has developed the 'Goodbody' brand - CBD you can trust. Under the Goodbody brand umbrella are the Goodbody Botanicals range for the everyday and pharmaceutical markets and the Goodbody Wellness brand, with its addition of Vitamin D, as a premium CBD brand for the health and beauty spa market. 

 

The Goodbody range is available at retailers and direct to the consumer online through Goodbodystore.com and soon available in Europe. As part of our route to market the Company intends to focus on retail listings and selling directly online within Europe.

 

"We welcome the news of the EU's highest court ruling. As a UK and European company that is committed to working with regulators and delivering the highest quality CBD wellness products, this news helps to enable our expansion plans. We currently own extraction and production capabilities in Europe and see this large market as a key driver for our growth for not only our CBD isolate and distillate ingredients, but also for our Goodbody CBD brands!" said Henry Lees-Buckley, CEO of Sativa Wellness.

 

The directors of the Company accept responsibility for the contents of this announcement.


On behalf of the Board of Directors,

 

Henry Lees-Buckley
Chief Executive Officer
Sativa Group Plc
+44 (0) 20 7971 1255
enquiries@sativagroup.co.uk
www.sativagroup.co.uk

Joseph Colliver
Chief Financial Officer
Sativa Group Plc
+44 (0) 20 7971 1255
enquiries@sativagroup.co.uk
www.sativagroup.co.uk

Jason Dussault
Investor Relations and Communications
Sativa Wellness Group Inc. (formerly Stillcanna Inc.)
jason@sativawellnessgroup.com
www.sativawellnessgroup.com

AQSE Growth Market Corporate Advisor
Corporate Finance
Guy Miller/Allie Feuerlein
Peterhouse Capital Limited
+44 (0) 20 7220 9795
gm@peterhousecap.com

 

 

This information is provided by RNS, the news service of the . RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXFZMZMFFLGGZM ]]>